Answers are grounded in this paper and cite their sources.
Androgen deprivation has long been a therapeutic option in the treatment or prostate cancer since Huggins & Hodges described the effect of castration on the prostate gland [1].Since then, the results of a large number of retrospective and prospective studies helped support the important role of androgen deprivation in prostate cancer [2].However, increasing attention has been focused on the possible side effects of androgen deprivation [3].Thus, the importance of understanding the mode of action, types of available preparations, as well as the appropriate indications and supporting literature on the subject has never been greater.The gains achieved through the integration of androgen deprivation may be lost if androgen deprivation is used inappropriately with a resultant decrease in the risk-benefit ratio.A comprehensive review of androgen deprivation in localized prostate cancer will include its use in the external beam, brachytherapy and prostatectomy settings per available literature.A review of the mechanism of action, side effects and new developments will be embarked upon.
No takes yet. Share an insight, caveat, or question.
May Abdel–Wahab (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: